Loading clinical trials...
Loading clinical trials...
The purpose of the study is to evaluate the efficacy of Seprafilm in reducing the incidence of bowel obstruction and to evaluate the incidence of all serious adverse events (SAEs) associated with the ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Genzyme, a Sanofi Company
NCT07432542 · Rectal Cancer Surgery, Middle and Low Rectal Cancer, and more
NCT06901544 · Intra-Abdominal Infections, Intestinal Obstruction, and more
NCT03773237 · Short Bowel Syndrome, Intestinal Fistula, and more
NCT04795388 · Mechanical Intestinal Obstruction
NCT04791566 · Intestinal Obstruction and Ileus, Perforated Viscus, and more
Mayo Clinic
Scottsdale, Arizona
Kaiser Permanente Medical Center
Los Angeles, California
USC School of Medicine
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions